Shift From Adalimumab Originator to Biosimilars in Denmark

被引:58
|
作者
Jensen, Thomas Bo [1 ]
Kim, Seoyoung C. [2 ]
Jimenez-Solem, Espen [1 ]
Bartels, Dorthe [3 ]
Christensen, Hanne Rolighed [1 ]
Andersen, Jon Traerup [1 ]
机构
[1] Copenhagen Univ Hosp Bispebjerg, Dept Clin Pharmacol, Bispebjerg Bakke 23,Entrance 20C,2nd Floor, DK-2400 Copenhagen NV, Denmark
[2] Brigham & Womens Hosp, Div Pharmacoepidemiol & Pharmacoecon, 75 Francis St, Boston, MA 02115 USA
[3] Amgros, Copenhagen, Denmark
关键词
D O I
10.1001/jamainternmed.2020.0338
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:902 / 903
页数:2
相关论文
共 50 条
  • [1] Effectiveness of Adalimumab Biosimilars and Originator for Psoriasis
    Phan, Duc Binh
    Bewley, Anthony P.
    Laws, Philip
    Mackenzie, Teena
    Smith, Catherine H.
    Griffiths, Christopher E. M.
    Lunt, Mark
    Warren, Richard B.
    Yiu, Zenas Z. N.
    JAMA DERMATOLOGY, 2025,
  • [2] IMPLEMENTATION OF ADALIMUMAB BIOSIMILARS IN DENMARK
    Jensen, T. B.
    Andersen, Traerup J.
    Kim, S. C.
    Kjellberg, J.
    Bartels, D.
    Christensen, Rolighed H.
    Solem, Jimenez E.
    VALUE IN HEALTH, 2019, 22 : S425 - S425
  • [3] Adalimumab originator versus adalimumab biosimilars in inflammatory bowel disease in Australia
    Anderson, Emilia
    Waller, Karen
    Tamilarasan, Aravind Gokul
    Lin, Huiyu
    Paramsothy, Sudarshan
    Leong, Rupert W.
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2023, 23 (08) : 819 - 825
  • [4] Outcomes Following a Mandatory Nonmedical Switch From Adalimumab Originator to Adalimumab Biosimilars in Patients With Psoriasis
    Loft, Nikolai
    Egeberg, Alexander
    Rasmussen, Mads Kirchheiner
    Bryld, Lars Erik
    Nissen, Christoffer Valdemar
    Dam, Tomas Norman
    Ajgeiy, Kawa Khaled
    Iversen, Lars
    Skov, Lone
    JAMA DERMATOLOGY, 2021, 157 (06) : 676 - 683
  • [5] Switching back to originator adalimumab from biosimilars in psoriasis: A cohort study from BADBIR
    Phan, Duc Binh
    Lunt, Mark
    Warren, Richard B.
    Yiu, Zenas Z. N.
    JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2025,
  • [6] Adalimumab originator and biosimilars in global inflammatory bowel disease treatment
    Yiu, Tsz Hong
    Nakase, Hiroshi
    Leung, Wai Keung
    Lin, Huiyu
    Banerjee, Rupa
    Anderson, Emilia
    Leong, Rupert
    JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 2024, 39 : 173 - 174
  • [7] Safety of biosimilars compared with originator adalimumab for psoriasis: a multinational cohort study
    Phan, Duc Binh
    Jourdain, Hugo
    Descalzo-Gallego, Miguel Angel
    Gonzalez-Quesada, Alicia
    Zureik, Mahmoud
    Rivera-Diaz, Raquel
    Sahuquillo-Torralba, Antonio
    Lunt, Mark
    Garcia-Doval, Ignacio
    Sbidian, Emilie
    Warren, Richard
    Yiu, Zenas
    BRITISH JOURNAL OF DERMATOLOGY, 2024, 191
  • [8] NON-MEDICAL SWITCH BETWEEN ADALIMUMAB BIOSIMILARS AND FROM THE ORIGINATOR ADALIMUMAB TO BIOSIMILARS IN INFLAMMATORY BOWEL DISEASE PATIENTS - A MULTICENTRE STUDY ON EFFICACY AND DRUG SUSTAINABILITY
    Lontai, Livia
    Gonczi, Lorant
    Balogh, Fruzsina
    Komlodi, Nora
    Resal, Tamas
    Farkas, Klaudia
    Molnar, Tamas
    Miheller, Pal
    Golovics, Petra A.
    Schafer, Eszter
    Szamosi, Tamas
    Ilias, Akos
    Lakatos, Peter L.
    GASTROENTEROLOGY, 2022, 162 (07) : S606 - S606
  • [9] Non-medical switch between adalimumab biosimilars and from the originator adalimumab to biosimilars in inflammatory bowel disease patients - a multicentre study on efficacy and drug sustainability
    Lontai, L.
    Gonczi, L.
    Balogh, F.
    Komlodi, N.
    Resal, T.
    Farkas, K.
    Molnar, T.
    Golovics, P.
    Schafer, E.
    Szamosi, T.
    Miheller, P.
    Ilias, A.
    Lakatos, P. L.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I518 - I519
  • [10] Non-medical switch between adalimumab biosimilars and from the originator adalimumab to biosimilars in inflammatory bowel disease patients - a multicentre study on efficacy and drug sustainability
    Lontai, L.
    Gonczi, L.
    Balogh, F.
    Komlodi, N.
    Resal, T.
    Farkas, K.
    Molnar, T.
    Golovics, P.
    Schafer, E.
    Szamosi, T.
    Miheller, P.
    Ilias, A.
    Lakatos, P. L.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I518 - I519